Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (311-320 of 498) with videos related to

Pageof 50
Sort By:
The Journal of Urology|July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN TrialSoumyajit Roy, Yilun Sun, Kim N Chi, et al.
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
<i>CDKN1B</i> Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate CancerFarzana A Faisal, Sanjana Murali, Harsimar Kaur, et al.
American Journal of Clinical Oncology|December 26, 2015
Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving RadiotherapyFabio Ynoe de Moraes, Elton Trigo Teixeira Leite, Dan A Hamstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
A Comprehensive Assessment of <sup>68</sup>Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 PatientsMonica Abghari-Gerst, Wesley R Armstrong, Kathleen Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate CancerNeil R Parikh, Eric M Chang, Nicholas G Nickols, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2021
Association Between Physician- and Patient-Reported Symptoms in Patients Treated With Definitive Radiation Therapy for Locally Advanced Lung Cancer in a Statewide ConsortiumJoel R Wilkie, Kimberly A Hochstedler, Matthew J Schipper, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
European Urology|May 22, 2024
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized TrialsPraful Ravi, Wanling Xie, Marc Buyse, et al.
Pageof 50

Showing results (311-320 of 498) with videos related to

Sort By:
Pageof 50
The Journal of Urology|July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN TrialSoumyajit Roy, Yilun Sun, Kim N Chi, et al.
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
<i>CDKN1B</i> Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate CancerFarzana A Faisal, Sanjana Murali, Harsimar Kaur, et al.
American Journal of Clinical Oncology|December 26, 2015
Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving RadiotherapyFabio Ynoe de Moraes, Elton Trigo Teixeira Leite, Dan A Hamstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2021
A Comprehensive Assessment of <sup>68</sup>Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 PatientsMonica Abghari-Gerst, Wesley R Armstrong, Kathleen Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate CancerNeil R Parikh, Eric M Chang, Nicholas G Nickols, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2021
Association Between Physician- and Patient-Reported Symptoms in Patients Treated With Definitive Radiation Therapy for Locally Advanced Lung Cancer in a Statewide ConsortiumJoel R Wilkie, Kimberly A Hochstedler, Matthew J Schipper, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
European Urology|May 22, 2024
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized TrialsPraful Ravi, Wanling Xie, Marc Buyse, et al.
Pageof 50